Direct oral anticoagulants vs non-vitamin K antagonist in atrial fibrillation: A prospective, propensity score adjusted cohort study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Marco,Marietta

第一单位： Hematology Unit, Azienda Ospedaliero-Universitaria, Modena, Italy. Electronic address: marco.marietta@unimore.it.

作者： Marco,Marietta ^[1] ; Federico,Banchelli ^[2] ; Piercamillo,Pavesi ^[3] ; Cesare,Manotti ^[4] ; Roberto,Quintavalla ^[4] ; Tiziana,Sinigaglia ^[5] ; Giuliana,Guazzaloca ^[6] ; Corrado,Pattacini ^[7] ; Stefano,Urbinati ^[8] ; Vincenzo Livio,Malavasi ^[9] ; Giuseppe,Boriani ^[9] ; Claudio,Voci ^[10] ; Roberto,D'Amico ^[11] ; Nicola,Magrini ^[12]

作者单位： Hematology Unit, Azienda Ospedaliero-Universitaria, Modena, Italy. Electronic address: marco.marietta@unimore.it. ^[1] Hematology Unit, Azienda Ospedaliero-Universitaria, Modena, Italy. ^[2] Cardiology Department, Maggiore Hospital, Bologna, Italy. ^[3] Department of Internal Medicine, Azienda Ospedaliero-Universitaria di Parma, Italy. ^[4] Cardiovascular Medicine Unit, Azienda Ospedaliero-Universitaria, Modena, Italy. ^[5] Department of Angiology and Blood Coagulation, S. Orsola-Malpighi University Hospital, Bologna, Italy. ^[6] Haemostasis Centre, Fidenza-Vaio Hospital, Fidenza, Italy. ^[7] Cardiology Department, Bellaria Hospital, AUSL of Bologna, Italy. ^[8] Cardiology Division, Department of Diagnostics, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy. ^[9] Servizio Strutture, Tecnologie e Sistemi Informativi, Regione Emilia-Romagna, Bologna, Italy. ^[10] Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Italy. ^[11] World Health Organization, Geneva, Switzerland. ^[12]

关键词 Anti-vitamin k Apixaban Atrial fibrillation Dabigatran Direct oral anticoagulants Propensity score Rivaroxaban